CRISPR Therapeutics Announces European Patent for CRISPR/Cas … – GlobeNewswire (press release)
|
CRISPR Therapeutics Announces European Patent for CRISPR/Cas …
GlobeNewswire (press release) BASEL, Switzerland, March 28, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP) reported that the European Patent Office (EPO) has … |
